Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8.78%
operating margin TTM
-8.86%
revenue TTM
196.88 Million
revenue per share TTM
3.99$
valuation ratios | |
|---|---|
| pe ratio | -112.00 |
| peg ratio | -3.76 |
| price to book ratio | 15.89 |
| price to sales ratio | 8.35 |
| enterprise value multiple | -711.82 |
| price fair value | 15.89 |
profitability ratios | |
|---|---|
| gross profit margin | 79.92% |
| operating profit margin | -8.86% |
| pretax profit margin | -8.65% |
| net profit margin | -8.78% |
| return on assets | -5.28% |
| return on equity | -16.47% |
| return on capital employed | -6.69% |
liquidity ratios | |
|---|---|
| current ratio | 3.31 |
| quick ratio | 3.16 |
| cash ratio | 1.76 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 92.53 |
| operating cycle | 175.41 |
| days of payables outstanding | 46.87 |
| cash conversion cycle | 128.54 |
| receivables turnover | 4.40 |
| payables turnover | 7.79 |
| inventory turnover | 3.94 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.41 |
| debt equity ratio | 1.09 |
| long term debt to capitalization | 0.51 |
| total debt to capitalization | 0.52 |
| interest coverage | -3.76 |
| cash flow to debt ratio | 0.14 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.76 |
| cash per share | 6.46 |
| operating cash flow per share | 0.77 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 0.14 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 119.50 |
Frequently Asked Questions
When was the last time Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) reported earnings?
Mirum Pharmaceuticals, Inc. (MIRM) published its most recent earnings results on 04-11-2025.
What is Mirum Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)'s trailing twelve months ROE is -16.47%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Mirum Pharmaceuticals, Inc. (MIRM) currently has a ROA of -5.28%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MIRM's net profit margin stand at?
MIRM reported a profit margin of -8.78% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MIRM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.31 in the most recent quarter. The quick ratio stood at 3.16, with a Debt/Eq ratio of 1.09.